Table 4 Cox regression—disease free survival.
 | Univariate | Multivariable | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | |
Gender | ||||||
Female | Reference | Reference | Â | Reference | Reference | Â |
Male | 1.38 | (1.08–1.77) | 0.011* | 1.22 | (0.94–1.58) | 0.131 |
Age | 1.01 | (1.00–1.02) | 0.090 |  |  |  |
GNRI | ||||||
 ≥ 92 | Reference | Reference |  | Reference | Reference |  |
 < 92 | 2.19 | (1.65–2.90) | < 0.001** | 1.90 | (1.42–2.54) |  < 0.001** |
Performance status ECOG | ||||||
0 | Reference | Reference | Â | Â | Â | Â |
1 | 1.15 | (0.78–1.68) | 0.484 |  |  |  |
2–4 | 1.35 | (0.86–2.11) | 0.193 |  |  |  |
Comorbidity | ||||||
HTN | 1.02 | (0.79–1.31) | 0.898 |  |  |  |
DM | 1.36 | (1.02–1.82) | 0.036* | 1.19 | (0.88–1.61) | 0.271 |
COPD/asthema | 2.12 | (1.21–3.71) | 0.009** | 2.06 | (0.98–3.70) | 0.113 |
CAD | 1.28 | (0.73–2.23) | 0.394 |  |  |  |
Creatinine > 1.5 mg/dL | 1.28 | (0.97–1.69) | 0.078 |  |  |  |
Smoking status | ||||||
Never | Reference | Reference | Â | Â | Â | Â |
Current/former | 1.13 | (0.86–1.50) | 0.372 |  |  |  |
Preoperative renal function | ||||||
eGFR ≥ 30 ml/min/1.73m2 | Reference | Reference |  |  |  |  |
eGFR < 30 ml/min/1.73m2 | 1.01 | (0.76–1.35) | 0.942 |  |  |  |
History of uremia | ||||||
Negative | Reference | Reference | Â | Â | Â | Â |
Positive | 1.08 | (0.77–1.53) | 0.644 |  |  |  |
Surgical margin | ||||||
Negative | Reference | Reference | Â | Reference | Reference | Â |
Positive | 3.11 | (2.22–4.36) | < 0.001** | 1.68 | (1.13–2.49) | 0.010* |
Pathological T | ||||||
T1 | Reference | Reference | Â | Reference | Reference | Â |
T2 | 1.35 | (0.89–2.02) | 0.154 | 1.15 | (0.75–1.75) | 0.520 |
T3 | 1.67 | (1.25–2.22) | < 0.001** | 1.14 | (0.82–1.60) | 0.436 |
T4 | 4.46 | (2.94–6.76) |  < 0.001** | 1.89 | (1.06–3.37) | 0.031* |
Pathological N | ||||||
N0 | Reference | Reference | Â | Reference | Reference | Â |
N1 | 1.64 | (0.89–3.01) | 0.110 | 0.99 | (0.53–1.86) | 0.984 |
N2–3 | 2.90 | (1.90–4.44) | < 0.001** | 1.14 | (0.68–1.89) | 0.626 |
Tumor grade | ||||||
Low | Reference | Reference | Â | Reference | Reference | Â |
High | 2.37 | (1.35–4.14) | 0.003** | 1.61 | (0.90–2.89) | 0.110 |
Lymphovascular invasion | ||||||
Negative | Reference | Reference | Â | Reference | Reference | Â |
Positive | 2.53 | (1.94–3.31) |  < 0.001** | 1.67 | (1.19–2.35) | 0.003** |